EXEMPA LIN MET XR 12.5/2.5/1000MG TAB

EXEMPA LIN MET XR is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 12.5mg, Linagliptin 2.5mg, and Metformin HCL 1000mg—three proven antidiabetic agents working synergistically to improve glycemic control. Empagliflozin helps reduce blood glucose by promoting urinary glucose excretion, while Linagliptin enhances insulin secretion by inhibiting DPP-4 enzymes. Metformin improves insulin sensitivity and reduces hepatic glucose production. This combination addresses multiple pathways of hyperglycemia, making it ideal for patients requiring intensive glucose management. The extended-release formulation ensures steady medication levels throughout the day, improving compliance and therapeutic outcomes. Suitable for adults with type 2 diabetes when diet and exercise alone are insufficient. Always consult your healthcare provider before use. Store in a cool, dry place away from direct sunlight.